Cargando…
Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis
OBJECTIVE: To study the burden of neurodevelopmental diseases (NDDs) via cost-of-illness analysis of Chinese patients with genetic diagnosis. METHODS: We recruited NDD patients (0–18 years old) with genetic diagnosis (GD) from September 1, 2020 to January 30, 2021. We gathered basic information on t...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126321/ https://www.ncbi.nlm.nih.gov/pubmed/35615033 http://dx.doi.org/10.3389/fpubh.2022.887796 |
_version_ | 1784712101071159296 |
---|---|
author | Xie, Donghua Duan, Ruoyu Li, Chen Xie, Zhiqun Wang, Aihua Xiong, Lili Wei, Jianhui Xi, Hui Fang, Junqu Yan, Huifang Wang, Junyu Zhang, Yu Mao, Xiao Wang, Jingmin Wang, Hua |
author_facet | Xie, Donghua Duan, Ruoyu Li, Chen Xie, Zhiqun Wang, Aihua Xiong, Lili Wei, Jianhui Xi, Hui Fang, Junqu Yan, Huifang Wang, Junyu Zhang, Yu Mao, Xiao Wang, Jingmin Wang, Hua |
author_sort | Xie, Donghua |
collection | PubMed |
description | OBJECTIVE: To study the burden of neurodevelopmental diseases (NDDs) via cost-of-illness analysis of Chinese patients with genetic diagnosis. METHODS: We recruited NDD patients (0–18 years old) with genetic diagnosis (GD) from September 1, 2020 to January 30, 2021. We gathered basic information on the details of diagnosis, as well as the direct medical cost, direct non-healthcare cost and indirect cost before and after receiving GD. We corrected the cost for time biases by calculating the cost per day for each patient. RESULTS: For the 502 patients with NDDs, the mean age was 4.08 ± 3.47. The household income was 0.6 (0.4, 1.0) 10,000 CNY per-month on average. The direct medical cost, direct non-healthcare cost and indirect cost were 12.27 (7.36, 22.23) 10,000 CNY, 1.45 (0.73, 2.69)10,000 CNY and 14.14(4.80, 28.25) 10,000 CNY per patient, respectively. Every patient received 1.20 (0.34, 3.60) 10,000 CNY on average (15.91%) from insurance. The daily total cost after receiving GD were ~62.48% lower than those before GD (191.59 CNY vs. 71.45 CNY). The descend range of lab cost (95.77%, P < 0.05) was the largest, followed by drugs (91.39%, P < 0.05), hospitalization (90.85%, P < 0.05), and consultation (57.41%, P < 0.05). The cost of rehabilitation kept slightly increasing but there were no significant differences (P > 0.05). The daily direct medical cost of each patient fell by 75.26% (P < 0.05) from 311.79 CNY to 77.14 CNY when the diagnostic age was younger than 1, and declined by 49.30% (P < 0.05) and 8.97% (P > 0.05) when the diagnostic age was 1–3 and older than 3, respectively. CONCLUSIONS: Early genetic diagnosis is crucial for to reducing the burden of disease because of the amount of money spent was lower when they are diagnosed at younger age. Patients with NDDs can incur a heavy economic burden, especially in rehabilitation cost and indirect cost, because the insurance coverage for patients is low, so it is urgent for governments to pay more attention to these issues. |
format | Online Article Text |
id | pubmed-9126321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91263212022-05-24 Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis Xie, Donghua Duan, Ruoyu Li, Chen Xie, Zhiqun Wang, Aihua Xiong, Lili Wei, Jianhui Xi, Hui Fang, Junqu Yan, Huifang Wang, Junyu Zhang, Yu Mao, Xiao Wang, Jingmin Wang, Hua Front Public Health Public Health OBJECTIVE: To study the burden of neurodevelopmental diseases (NDDs) via cost-of-illness analysis of Chinese patients with genetic diagnosis. METHODS: We recruited NDD patients (0–18 years old) with genetic diagnosis (GD) from September 1, 2020 to January 30, 2021. We gathered basic information on the details of diagnosis, as well as the direct medical cost, direct non-healthcare cost and indirect cost before and after receiving GD. We corrected the cost for time biases by calculating the cost per day for each patient. RESULTS: For the 502 patients with NDDs, the mean age was 4.08 ± 3.47. The household income was 0.6 (0.4, 1.0) 10,000 CNY per-month on average. The direct medical cost, direct non-healthcare cost and indirect cost were 12.27 (7.36, 22.23) 10,000 CNY, 1.45 (0.73, 2.69)10,000 CNY and 14.14(4.80, 28.25) 10,000 CNY per patient, respectively. Every patient received 1.20 (0.34, 3.60) 10,000 CNY on average (15.91%) from insurance. The daily total cost after receiving GD were ~62.48% lower than those before GD (191.59 CNY vs. 71.45 CNY). The descend range of lab cost (95.77%, P < 0.05) was the largest, followed by drugs (91.39%, P < 0.05), hospitalization (90.85%, P < 0.05), and consultation (57.41%, P < 0.05). The cost of rehabilitation kept slightly increasing but there were no significant differences (P > 0.05). The daily direct medical cost of each patient fell by 75.26% (P < 0.05) from 311.79 CNY to 77.14 CNY when the diagnostic age was younger than 1, and declined by 49.30% (P < 0.05) and 8.97% (P > 0.05) when the diagnostic age was 1–3 and older than 3, respectively. CONCLUSIONS: Early genetic diagnosis is crucial for to reducing the burden of disease because of the amount of money spent was lower when they are diagnosed at younger age. Patients with NDDs can incur a heavy economic burden, especially in rehabilitation cost and indirect cost, because the insurance coverage for patients is low, so it is urgent for governments to pay more attention to these issues. Frontiers Media S.A. 2022-05-09 /pmc/articles/PMC9126321/ /pubmed/35615033 http://dx.doi.org/10.3389/fpubh.2022.887796 Text en Copyright © 2022 Xie, Duan, Li, Xie, Wang, Xiong, Wei, Xi, Fang, Yan, Wang, Zhang, Mao, Wang and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Xie, Donghua Duan, Ruoyu Li, Chen Xie, Zhiqun Wang, Aihua Xiong, Lili Wei, Jianhui Xi, Hui Fang, Junqu Yan, Huifang Wang, Junyu Zhang, Yu Mao, Xiao Wang, Jingmin Wang, Hua Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis |
title | Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis |
title_full | Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis |
title_fullStr | Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis |
title_full_unstemmed | Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis |
title_short | Study on the Economic Burden of Neurodevelopmental Diseases on Patients With Genetic Diagnosis |
title_sort | study on the economic burden of neurodevelopmental diseases on patients with genetic diagnosis |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126321/ https://www.ncbi.nlm.nih.gov/pubmed/35615033 http://dx.doi.org/10.3389/fpubh.2022.887796 |
work_keys_str_mv | AT xiedonghua studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT duanruoyu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT lichen studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT xiezhiqun studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT wangaihua studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT xionglili studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT weijianhui studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT xihui studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT fangjunqu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT yanhuifang studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT wangjunyu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT zhangyu studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT maoxiao studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT wangjingmin studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis AT wanghua studyontheeconomicburdenofneurodevelopmentaldiseasesonpatientswithgeneticdiagnosis |